New consultations: formulary actions, wound management formulary, 30 day TA for daratumumab

North East and North Cumbria (NENC) ICB are seeking NENC system-wide views on implementation of:

  • NICE 30 day TA for daratumumab with bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma – consultation closes 5pm on Monday 19th October
  • NENC Formulary Working Group actions – September 2026 – consultation closes 5pm on Monday 2nd November
  • NENC wound management formulary – consultation closes 5pm on Monday 2nd November

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to NTAG and used to inform implementation of the decisions in NENC.

 All active consultations can be accessed at https://ntag.nhs.uk/consultations/.


New consultations: methylphenidate shared care and 30 day TA for mirdametinib

North East and North Cumbria (NENC) ICB are seeking NENC system-wide views on implementation of:

  • Shared care protocol – Methylphenidate for patients within Paediatric Oncology – consultation closes at 5pm on Wednesday 14th October.
  • NICE 30 day TA – mirdametinib for treating symptomatic and inoperable plexiform neurofibromas associated with neurofibromatosis type 1 in people 2 to 17 years – consultation closes at 5pm on Monday 19th October

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to NTAG and used to inform implementation of the decisions in NENC.

 All active consultations can be accessed at https://ntag.nhs.uk/consultations/.


New consultations: clinical guidelines and pathways

Following the September meeting of the Clinical Guidelines and Pathways Group, North East and North Cumbria (NENC) ICB are seeking NENC system-wide views on implementation of the following:

  • Tissue viability pathways – closing 2nd October
  • Primary care guideline for management of insomnia – closing 2nd October
  • Clinical pathway for prescribing and monitoring GnRH antagonists for endometriosis – closing 9th October
  • Transanal irrigation pathway – closing 9th October
  • Hypogonadism primary care guidelines – closing 9th October

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to NTAG and used to inform implementation of the decisions in NENC.

 All active consultations can be accessed at https://ntag.nhs.uk/consultations/.


New consultation: NICE TAs August 2026

North East and North Cumbria (NENC) ICB are seeking NENC system-wide views on implementation of NICE TAs published in July 2026. This consultation will run for four weeks and closes at 5pm on Tuesday 6th October.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to NTAG and used to inform implementation of the decisions in NENC.

 All active consultations can be accessed at https://ntag.nhs.uk/consultations/.


New consultation: July NICE TAs

North East and North Cumbria (NENC) ICB are seeking NENC system-wide views on implementation of NICE TAs published in July 2026. This consultation will run for four weeks and closes at 5pm on Monday 21st September.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to NTAG and used to inform implementation of the decisions in NENC.

 All active consultations can be accessed at https://ntag.nhs.uk/consultations/.


New consultation: NICE 30-day TA for deuruxolitinib for severe alopecia areata

North East and North Cumbria (NENC) ICB are seeking system-wide views on adoption of a NICE 30-day TA for deuruxolitinib for severe alopecia areata.

This consultation is open for 2 weeks and closes at 5pm on Thursday 30th July 2026. Visit the consultation page here.


New consultation: NENC Green+ Information leaflet: Efmody for the treatment of Congenital Adrenal Hyperplasia

North East and North Cumbria (NENC) ICB are seeking system-wide views on adoption of a NENC Green+ Information leaflet: Efmody for the treatment of Congenital Adrenal Hyperplasia

This consultation is open for 4 weeks and closes at 5pm on Wednesday 12th August 2026. Visit the consultation page here.


New consultation: NICE 30-day TA for atogepant for treating migraine

North East and North Cumbria (NENC) ICB are seeking system-wide views on adoption of a NICE 30-day TA for atogepant for treating migraine.

This consultation is open for 2 weeks and closes at 5pm on Wednesday 15th July 2026. Visit the consultation page here.


New consultations: constipation guideline and melatonin information

North East and North Cumbria (NENC) ICB are seeking system-wide views on two new consultations:

Comments are welcomed from across the system, including residents and patients of NENC. Comments will be returned to NTAG or one of its subgroups and used to inform implementation of the decisions in NENC.

These consultations will run for four weeks and close at 5pm on Wednesday 24th June 2026. All active consultations can be accessed at https://ntag.nhs.uk/consultations/.


New consultations: NICE TAs for April and four primary care guidelines

North East and North Cumbria (NENC) ICB are seeking system-wide views on five new consultations:

Comments are welcomed from across the system, including residents and patients of NENC. Comments will be returned to NTAG or one of its subgroups and used to inform implementation of the decisions in NENC.

These consultations will run for four weeks and close at 5pm on Monday 8th June 2026. All active consultations can be accessed at https://ntag.nhs.uk/consultations/.